{"DataElement":{"publicId":"7118703","version":"1","preferredName":"Tumor Mass Cholangiocarcinoma Histologic Type","preferredDefinition":"The type of tissue in which an intrahepatic bile duct, the hepatic duct, or the common bile duct distal to the insertion of the cystic duct  tumor originated.","longName":"6796604v1.0:7114173v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"6796604","version":"1","preferredName":"Tumor Mass Site","preferredDefinition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells._The anatomic site of the tumor.","longName":"4976411v1.0:6796602v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"4976411","version":"1","preferredName":"Tumor Mass","preferredDefinition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","longName":"C98275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Mass","conceptCode":"C98275","definition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1DC5FA96-6845-8A34-E050-BB89AD4344BC","latestVersionIndicator":"Yes","beginDate":"2015-08-20","endDate":null,"createdBy":"DAVISJ","dateCreated":"2015-08-20","modifiedBy":"ONEDATA","dateModified":"2015-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6796602","version":"1","preferredName":"Site of Tumor","preferredDefinition":"The anatomic site of the tumor.","longName":"C157120","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Site of Tumor","conceptCode":"C157120","definition":"The anatomic site of the tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C3BB458-85EF-345F-E053-F662850AA4D3","latestVersionIndicator":"Yes","beginDate":"2019-06-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-06-26","modifiedBy":"ONEDATA","dateModified":"2019-06-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C3BB458-8600-345F-E053-F662850AA4D3","latestVersionIndicator":"Yes","beginDate":"2019-06-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-06-26","modifiedBy":"KNABLEJ","dateModified":"2020-01-02","changeDescription":"1/2/20 jk Released per CPTAC SME (Linda) for PRAD Baseline CRF.   7/26/19 jk revised OC concept per CPTAC input.  6/26/19 jk created for CPTAC Baseline CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7114173","version":"1","preferredName":"Cholangiocarcinoma Histologic Type","preferredDefinition":"A carcinoma that arises from the intrahepatic bile ducts, the hepatic ducts, or the common bile duct distal to the insertion of the cystic duct. The vast majority of tumors are adenocarcinomas._Refers to the type of tissue in which a tumor originated._Something distinguishable as an identifiable class based on common qualities.","longName":"TMR_CHOL_HIST_TP","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Adenocarcinoma","valueDescription":"Adenocarcinoma","ValueMeaning":{"publicId":"2831117","version":"1","preferredName":"Adenocarcinoma","longName":"2831117","preferredDefinition":"carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"61F598EF-7D06-BDE9-E040-BB89AD43552F","latestVersionIndicator":"Yes","beginDate":"2009-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB1232A-EBDB-704D-E053-F662850A3107","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Cholangiocarcinoma","valueDescription":"Cholangiocarcinoma","ValueMeaning":{"publicId":"4722725","version":"1","preferredName":"Cholangiocarcinoma","longName":"4722725","preferredDefinition":"A carcinoma that arises from the intrahepatic biliary tree (intrahepatic cholangiocarcinoma) or from the junction, or adjacent to the junction, of the right and left hepatic ducts (hilar cholangiocarcinoma). Grossly, the malignant lesions are solid, nodular, and grayish. Morphologically, the vast majority of cases are adenocarcinomas. Signs and symptoms include malaise, weight loss, right upper quadrant abdominal pain, and night sweats. Early detection is difficult and the prognosis is generally poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cholangiocarcinoma","conceptCode":"C4436","definition":"A carcinoma that arises from the intrahepatic bile ducts, the hepatic ducts, or the common bile duct distal to the insertion of the cystic duct. The vast majority of tumors are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-1D7B-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB1232A-EBE6-704D-E053-F662850A3107","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other Histologic Type","ValueMeaning":{"publicId":"7331757","version":"1","preferredName":"Other Histologic Type","longName":"7331757","preferredDefinition":"A selected option that indicated an other histologic type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other Histologic Type","conceptCode":"C159613","definition":"A selected option that indicated an other histologic type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A80C0DF2-F90A-58A8-E053-4EBD850A7EC2","latestVersionIndicator":"Yes","beginDate":"2020-06-14","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A80C73DE-3953-758F-E053-4EBD850A86BE","beginDate":"2019-12-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-06-14","modifiedBy":"ONEDATA","dateModified":"2020-06-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7114172","version":"1","preferredName":"Cholangiocarcinoma Histologic Type Type","preferredDefinition":"A carcinoma that arises from the intrahepatic bile ducts, the hepatic ducts, or the common bile duct distal to the insertion of the cystic duct. The vast majority of tumors are adenocarcinomas.:Refers to the type of tissue in which a tumor originated.:Something distinguishable as an identifiable class based on common qualities.","longName":"C4436:C61478:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cholangiocarcinoma","conceptCode":"C4436","definition":"A carcinoma that arises from the intrahepatic bile ducts, the hepatic ducts, or the common bile duct distal to the insertion of the cystic duct. The vast majority of tumors are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histologic Type","conceptCode":"C61478","definition":"Refers to the type of tissue in which a tumor originated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AB1232A-EBB4-704D-E053-F662850A3107","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AB1232A-EBC5-704D-E053-F662850A3107","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"COLBERTM","dateModified":"2022-09-19","changeDescription":"6/14/20 jk upd Other PV to use CPTAC CUI for \"Other Histologic Type\".  12/27/19 jk created for CPTAC CHOL baseline CRF.","administrativeNotes":"9/19/22 Released bc CDE was released. mr;","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6776762","version":"1","longName":"Bile duct and Liver","context":"OCCPR"},{"publicId":"6779538","version":"1","longName":"CHOL Baseline","context":"OCCPR"},{"publicId":"6779539","version":"1","longName":"CHOL Local Pathology","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Histologic Type","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9B01B763-B10D-1D73-E053-F662850AEBFB","latestVersionIndicator":"Yes","beginDate":"2019-12-31","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-31","modifiedBy":"COLBERTM","dateModified":"2022-09-19","changeDescription":"12/31/19 jk created for CPTAC CHOL baseline CRF.","administrativeNotes":"7/7/22 Added CSI for CPTAC CHOL Local Path. mr; 9/19/22 Released/Qualified per jk for CPTAC. mr;","unresolvedIssues":null,"deletedIndicator":"No"}}